Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study

Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study

Statins constitute the mainstay treatment for atherosclerotic cardiovascular disease, which is associated with the risk of new-onset diabetes mellitus (NODM). However, the effects of individual statins on the risk of NODM remain unclear. We recruited 48,941 patients taking one of the three intereste...

Full description

Bibliographic Details
Main Authors: Wei-Ting Liu, Chin Lin, Min-Chien Tsai, Cheng-Chung Cheng, Sy-Jou Chen, Jun-Ting Liou, Wei-Shiang Lin, Shu-Meng Cheng, Chin-Sheng Lin, Tien-Ping Tsao
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Biomedicines
Subjects:
statins
new-onset diabetes mellitus
atherosclerotic cardiovascular disease
Online Access:https://www.mdpi.com/2227-9059/8/11/499

Internet

https://www.mdpi.com/2227-9059/8/11/499

Similar Items